Publishing Strategy3 min readUpdated Apr 2, 2026

Is RSC Advances Predatory? A Practical Journal Verdict

RSC Advances is not predatory. It is published by the Royal Society of Chemistry, a learned society with a Royal Charter dating to 1841. The real question is whether it is the right strategic fit for your paper.

Author contextSenior Researcher, Oncology & Cell Biology. Experience with Nature Medicine, Cancer Cell, Journal of Clinical Oncology.View profile

Next step

Choose the next useful decision step first.

Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.

Open Journal Fit ChecklistAnthropic Privacy Partner. Zero-retention manuscript processing.Run Free Readiness ScanOr find your best-fit journal in 30 seconds
Journal context

RSC Advances at a glance

Key metrics to place the journal before deciding whether it fits your manuscript and career goals.

Full journal profile
Impact factor4.6Clarivate JCR
Acceptance rate~60-70%Overall selectivity
Time to decision~60-90 days medianFirst decision
Open access APC~$1,200 GBPGold OA option

What makes this journal worth targeting

  • IF 4.6 puts RSC Advances in a visible tier — citations from papers here carry real weight.
  • Scope specificity matters more than impact factor for most manuscript decisions.
  • Acceptance rate of ~~60-70% means fit determines most outcomes.

When to look elsewhere

  • When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
  • If timeline matters: RSC Advances takes ~~60-90 days median. A faster-turnaround journal may suit a grant or job deadline better.
  • If OA is required: gold OA costs ~$1,200 GBP. Check institutional agreements before submitting.

Quick answer: RSC Advances is not predatory. It is published by the Royal Society of Chemistry, a chartered learned society founded in 1841, and is indexed in SCIE, Scopus, PubMed Central, and DOAJ with a JCR Impact Factor of 4.6. The question researchers should be asking is not about legitimacy but about strategic fit within the RSC portfolio and their field.

Why people ask the question

RSC Advances triggers this question because of a few specific factors:

  • In January 2021, RSC retracted 68 papers identified as paper mill products, the largest single batch retraction for the journal
  • At peak volume in 2016, the journal published over 13,300 articles per year, reaching mega-journal territory
  • Its 46% acceptance rate is higher than most specialty chemistry journals
  • Its positioning as the RSC's broad-scope, entry-level journal creates a perception that papers end up here when they cannot get into more selective RSC titles

None of these factors make the journal predatory. They do, however, explain why the question gets asked.

What is actually true about RSC Advances

The Royal Society of Chemistry is not a commercial publisher. It is a learned society and professional body operating under a Royal Charter, with roots in the Chemical Society of London (1841). RSC publishes approximately 40 journals, including Chemical Society Reviews (IF ~40) and Chemical Science (IF ~7.6).

RSC Advances uses single-blind peer review with 2-3 reviewers per submission and an average 27-day turnaround to first decision. Its APC is 2,100 GBP with full waivers for Research4Life Group A and B countries. The journal converted from subscription to gold open access in January 2017.

This is a society journal with genuine editorial infrastructure. That is a fundamentally different proposition from a journal with no institutional backing.

RSC Advances legitimacy evidence

Signal
Status
Detail
Publisher
Royal Society of Chemistry
Learned society, Royal Charter since 1841
IF (JCR 2024)
4.6
Exceeds some established RSC specialty titles
Indexing
SCIE + Scopus + PubMed Central + DOAJ
Full mainstream indexing
Acceptance rate
~46%
2-3 reviewers per submission, 27-day first decision
APC
£2,100
Waivers for Research4Life Group A/B countries
Beall's List
Never listed
No predatory publisher classification
Paper mill incident
68 retractions (Jan 2021)
RSC publicly acknowledged and enhanced screening
Volume trend
13,300 (2016) → ~3,800 (2025)
Substantial decline after OA conversion + scandal
SJR trajectory
1.113 (2014) → 0.667 (2021) → 0.777 (2024)
Recovering after crisis

Where the real risk sits

The concern with RSC Advances is not about fake publishing. It is about positioning and signal.

The specific considerations are:

  • The 2021 paper mill incident exposed that the journal's scale made it a target for organized fraud, though RSC's transparent response, publicly acknowledging screening failures and enhancing detection, is the opposite of how a predatory journal would respond
  • RSC also retracted 5 additional papers for compromised peer review involving fabricated referee reports
  • The journal's volume has dropped substantially from its 2016 peak of 13,300 articles to roughly 3,800 in 2025, partly reflecting the shift to APCs and partly the reputational impact of the paper mill scandal
  • Its SJR dropped from 1.113 in 2014 to 0.667 in 2021 before recovering to 0.777, reflecting the reputation trajectory through growth, crisis, and recovery

The risk is not that your paper will appear in a fake journal. The risk is that RSC Advances may send a weaker signal than a more selective RSC specialty journal or a focused society journal in your subfield.

Why the answer has to be case by case

Whether RSC Advances is the right venue depends entirely on what you are trying to accomplish.

For technically sound chemistry research that needs fast open-access publication through a society publisher, RSC Advances delivers real value: genuine peer review, strong indexing, PubMed Central visibility, and the RSC brand. Its IF of 4.6 actually exceeds some established RSC specialty titles like Dalton Transactions (IF ~3.5).

For work that could compete at more selective venues, targeting Chemical Science, Chemical Communications, or a specialty society journal will typically provide a stronger career signal.

The better question than "is RSC Advances predatory?"

For most authors, the useful question is:

Is RSC Advances the strongest venue I can realistically place this paper in, or would a more selective alternative serve my goals better?

That means checking:

  • whether your paper fits a focused RSC journal (Chemical Communications, Organic Chemistry Frontiers, Dalton Transactions) rather than the broad-scope option
  • whether the IF of 4.6 and PubMed Central indexing meet your institutional evaluation requirements
  • whether fast turnaround (27 days to first decision) is a meaningful advantage for your timeline
  • whether a non-OA RSC journal without APCs would be a better fit financially

Practical verdict

RSC Advances is not predatory by any reasonable definition. It is a society journal published by a Royal Charter organization with genuine peer review, strong indexing, and transparent editorial practices. The 2021 paper mill incident was a real failure, but RSC's public acknowledgment and corrective action demonstrated institutional integrity.

The decision is about strategic fit, not legitimacy. RSC Advances is a solid broad-scope option for technically sound chemistry. Whether it is the best option depends on your paper's competitiveness and your career goals.

If you are deciding where your chemistry paper fits, the best next reads are:

  • Is MDPI predatory?
  • Is Frontiers predatory?

If you want a direct assessment of whether RSC Advances or a more selective journal is the right match, manuscript readiness check can help.

Readiness check

Run the scan while the topic is in front of you.

See score, top issues, and journal-fit signals before you submit.

Get free manuscript previewAnthropic Privacy Partner. Zero-retention manuscript processing.See sample reportOr run a stats sanity check

Before you submit

A manuscript scope and readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.

Frequently asked questions

No. RSC Advances is published by the Royal Society of Chemistry, a learned society operating under a Royal Charter since 1841. It is indexed in SCIE, Scopus, PubMed Central, and DOAJ, with a JCR Impact Factor of 4.6.

In January 2021, RSC retracted 68 papers from RSC Advances identified as paper mill products. The papers shared common templates and contained image manipulation. RSC publicly acknowledged its screening should have been tighter and enhanced its detection processes.

Approximately 46%, with an average time to first decision of 27 days using 2-3 expert reviewers per submission. This is comparable to other broad-scope journals like Scientific Reports (40-50%) and PLOS ONE (~31%)).

RSC Advances (IF 4.6) is the broad-scope entry in the RSC portfolio. Chemical Society Reviews has an IF around 40, Chemical Science around 7.6. RSC Advances covers all chemistry and is less selective than the specialty titles, but its IF actually exceeds some established RSC journals.

The article processing charge is 2,100 GBP. Full waivers are available for authors in Research4Life Group A and B countries, and institutional Read and Publish agreements may cover the fee.

References

Sources

  1. 1. RSC Advances journal page, Royal Society of Chemistry.
  2. 2. Publisher retracting 68 articles suspected of being paper mill products, Retraction Watch.
  3. 3. RSC paper mill response, Royal Society of Chemistry.
  4. 4. Fake peer review hits RSC journals, Chemistry World.
  5. 5. Clarivate Journal Citation Reports (2024 release).
  6. 6. DOAJ listing for RSC Advances, DOAJ.

Before you upload

Choose the next useful decision step first.

Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.

Use the scan once the manuscript and target journal are concrete enough to evaluate.

Anthropic Privacy Partner. Zero-retention manuscript processing.

Internal navigation

Where to go next

Open Journal Fit Checklist